Proteins

Xentuzumab (anti-IGF1) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab (anti-IGF1) inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation.Purity&gt:95%

Xentuzumab (anti-IGF1) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab (anti-IGF1) inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation.Purity&gt:95%

Xentuzumab (anti-IGF1) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab (anti-IGF1) inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation.Purity&gt:95%

Purified endo-β-(1→4)-xylanase from Thermomyces lanuginosus produced by submerged fermentation of a genetically modified Aspergillus oryzae microorganism。 Studies show that the signal sequence found in the xylanase gene is critical for protein

Xylene cyanol FF.

Xylene cyanol FF.

Xylene cyanol FF.

Potent and selective FAK inhibitor.

Potent and selective FAK inhibitor.

Y-29794 oxalate.

Y-29794 oxalate.

SIRT1 activator.